Rare GI disease leads to 20-plus units of transfused blood

• by Teraya Smith

• October 5, 2026

NEJM Retracts Avacopan Vasculitis Study

"The primary end-point assessments in nine patients were readjudicated after database lock and trial unblinding"

• by Kathryn Wighton

• July 1, 2026

• 3 min

Can AI Aid Urine Drug Test Sign-Outs?

Researchers reported that an artificial intelligence workflow maintained high interpretive accuracy while reducing urine drug test sign-out time in a supervised clinical laboratory setting.

• by Andrea Surnit

• July 9, 2026

• 4 min

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

• by Kathryn Wighton

• June 26, 2026

• 3 min